Araştırma Makalesi

HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis

Cilt: 36 Sayı: 2026 30 Ocak 2026
PDF İndir
EN TR

HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis

Öz

Aims: Women who have undergone subtotal hysterectomy remain at risk for HPV infection and cervical cancer due to the preservation of cervical structure. This study aimed to assess the efficacy of HPV-based cervical cancer screening following subtotal hysterectomy and the rates of patient compliance. Methods: A group of 284 women who underwent subtotal hysterectomy was evaluated, and data on HPV testing, cytology, and demographics was collected. HPV positivity, genotype distribution, and cytological results were examined. Results: HPV positivity was observed in 14.4% of participants, with genotypes 16 and 18 being the most common types. Cytological abnormalities were identified in 21% of HPV-positive cases. The screening compliance rate was determined at 72.5%. Conclusions: HPV-based screening in women with cervical preservation following subtotal hysterectomy is a crucial and essential approach to mitigate cervical cancer risk. It is recommended to establish particular protocols for this group under national screening programs.

Anahtar Kelimeler

Subtotal hysterectomy, HPV screening, cervical cancer, cytology, genotype distribution

Destekleyen Kurum

Osmaniye State Hospital

Etik Beyan

The Osmaniye Korkut Ata University Health Sciences Research Ethics Committee, chaired by Prof. Dr. Hüsniye SAĞLIKER, convened on August 5, 2025, at 10:00 AM, and approval was obtained with decision number 7/25.

Teşekkür

We thank Osmaniye State Hospital and all healthcare personnel.

Kaynakça

  1. 1. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstet Gynecol. 2021 Jun 1;137(6):e100-e115.
  2. 2. Aleixo GF, Fonseca MCM, Bortolini MAT, Brito LGO, Castro RA. Total Versus Subtotal Hysterectomy: Systematic Review and Meta-analysis of Intraoperative Outcomes and Postoperative Short-term Events. Clin Ther. 2019 Apr;41(4):768-789.
  3. 3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12-9.
  4. 4. Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ; International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014 Feb 8;383(9916):524-32.
  5. 5. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstet Gynecol. 2016 Oct;128(4):e111-e130. 6. Andersen LL, Møller LM, Gimbel HM. Low adherence to cervical cancer screening after subtotal hysterectomy. Dan Med J. 2015 Dec;62(12):A5165.
  6. 7. Shoukry A, Yousri M. Cervical stump leiomyomata after supracervical hysterectomy; a case report with review of literature. BMC Womens Health. 2024 Sep 10;24(1):500.
  7. 8. Wang J, Zeng X, Min L, Li L. Cervical stump cancer after subtotal hysterectomy: a retrospective research of 127 cases from China and literature review. Clin Exp Obstet Gynecol. 2024;51(1):11.
  8. 9. Fram KM, Saleh S, Fram F, Fram R, Muhidat N, Abdaljaleel M, Sweis N, Khouri Z, Al-Qudah F. Subtotal hysterectomy reviewed: a stable or aperture for stump cervical malignancy. A referral hospital experience. Prz Menopauzalny. 2022 Dec;21(4):266-271.
  9. 10. Andrikos D, Andrikos A, Naem A, Ebertz O, Devassy R, De Wilde RL, et al. Advanced cervical stump cancer after laparoscopic subtotal hysterectomy: a case report of imaging, laparoscopic staging and treatment approach. BMC Womens Health. 2023;23(1):281.
  10. 11. Neis F, Reisenauer C, Kraemer B, Wagner P, Brucker S. Retrospective analysis of secondary resection of the cervical stump after subtotal hysterectomy: why and when? Arch Gynecol Obstet. 2021 Dec;304(6):1519-1526.

Kaynak Göster

APA
Kayar, İ., Çetin, F., Çetin, M., & Birge, Ö. (2026). HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis. Genel Tıp Dergisi, 36(2026), 1-7. https://doi.org/10.54005/geneltip.1777049
AMA
1.Kayar İ, Çetin F, Çetin M, Birge Ö. HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis. Genel Tıp Derg. 2026;36(2026):1-7. doi:10.54005/geneltip.1777049
Chicago
Kayar, İlkan, Ferhat Çetin, Mustafa Çetin, ve Özer Birge. 2026. “HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis”. Genel Tıp Dergisi 36 (2026): 1-7. https://doi.org/10.54005/geneltip.1777049.
EndNote
Kayar İ, Çetin F, Çetin M, Birge Ö (01 Ocak 2026) HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis. Genel Tıp Dergisi 36 2026 1–7.
IEEE
[1]İ. Kayar, F. Çetin, M. Çetin, ve Ö. Birge, “HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis”, Genel Tıp Derg, c. 36, sy 2026, ss. 1–7, Oca. 2026, doi: 10.54005/geneltip.1777049.
ISNAD
Kayar, İlkan - Çetin, Ferhat - Çetin, Mustafa - Birge, Özer. “HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis”. Genel Tıp Dergisi 36/2026 (01 Ocak 2026): 1-7. https://doi.org/10.54005/geneltip.1777049.
JAMA
1.Kayar İ, Çetin F, Çetin M, Birge Ö. HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis. Genel Tıp Derg. 2026;36:1–7.
MLA
Kayar, İlkan, vd. “HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis”. Genel Tıp Dergisi, c. 36, sy 2026, Ocak 2026, ss. 1-7, doi:10.54005/geneltip.1777049.
Vancouver
1.İlkan Kayar, Ferhat Çetin, Mustafa Çetin, Özer Birge. HPV Screening Following Subtotal Hysterectomy: Clinical Findings and Screening Adherence Analysis. Genel Tıp Derg. 01 Ocak 2026;36(2026):1-7. doi:10.54005/geneltip.1777049